These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7907060)

  • 1. Prognostic significance of ureteral obstruction in primary cervical cancer.
    Lee SK; Jones HW
    Int J Gynaecol Obstet; 1994 Jan; 44(1):59-65. PubMed ID: 7907060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer.
    Emmert C; Rassler J; Köhler U
    Arch Gynecol Obstet; 1997; 259(3):147-51. PubMed ID: 9187468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Affecting Survival Outcome After Percutaneous Nephrostomy as Palliative Urinary Diversion in Obstructive Uropathy due to Advance Cervical Cancer Patients.
    Noegroho BS; Kurniawan AP; Wijayanti Z; Mustafa A
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1211-1216. PubMed ID: 33906314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome and management of ureteral obstruction secondary to gastric cancer.
    Migita K; Watanabe A; Samma S; Ohyama T; Ishikawa H; Kagebayashi Y
    World J Surg; 2011 May; 35(5):1035-41. PubMed ID: 21387134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction.
    Gasparini M; Carroll P; Stoller M
    Urology; 1991 Nov; 38(5):408-12. PubMed ID: 1719688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative urinary diversion in carcinoma of the cervix.
    Meyer JE; Green TH; Yatsuhashi M
    Obstet Gynecol; 1980 Jan; 55(1):95-8. PubMed ID: 6153241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases.
    Heo JE; Jeon DY; Lee J; Ham WS; Choi YD; Jang WS
    Ann Surg Oncol; 2021 Apr; 28(4):2367-2373. PubMed ID: 33389298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of locally advanced cervical cancer presenting with obstructive uropathy: An institutional audit.
    Salunkhe R; Chopra S; Kulkarni S; Shetty N; Engineer R; Mahantshetty U; Ghosh J; Gupta S; Shrivastava SK
    Indian J Cancer; 2020; 57(4):416-422. PubMed ID: 33078748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous nephrostomy in gynecologic oncology patients.
    Soper JT; Blaszczyk TM; Oke E; Clarke-Pearson D; Creasman WT
    Am J Obstet Gynecol; 1988 May; 158(5):1126-31. PubMed ID: 2453117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonoperative urinary diversion for malignant ureteral obstruction.
    Zadra JA; Jewett MA; Keresteci AG; Rankin JT; St Louis E; Grey RR; Pereira JJ
    Cancer; 1987 Sep; 60(6):1353-7. PubMed ID: 3621117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer.
    Ekici S; Sahin A; Ozen H
    J Endourol; 2001 Oct; 15(8):827-9. PubMed ID: 11724123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
    Dhani FK; Daryanto B; Seputra KP
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operative retroperitoneal ureteral catheterization for obstructive uropathy in primary locally advanced carcinoma of the cervix: description of a technique and experience.
    Rose PG
    Gynecol Oncol; 1996 Apr; 61(1):79-82. PubMed ID: 8626122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of metallic stents for malignant ureteral obstruction in advanced cervical carcinoma.
    Lang EK; Winer AG; Abbey-Mensah G; Anne R; Allaei A; Friedman F; Thomas R; La Nasa J; Davis R
    J Endourol; 2013 May; 27(5):646-51. PubMed ID: 23199302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
    Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
    BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative urinary diversion in patients with advanced cervical cancer.
    Fukuoka M; Suzuki A; Fujii S; Okamura H
    Eur J Obstet Gynecol Reprod Biol; 1983 Dec; 16(4):293-8. PubMed ID: 6201402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.